HomeCompareMCK vs BEN

MCK vs BEN: Dividend Comparison 2026

MCK yields 0.38% · BEN yields 5.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BEN wins by $20.9K in total portfolio value
10 years
MCK
MCK
● Live price
0.38%
Share price
$860.19
Annual div
$3.28
5Y div CAGR
66.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.3K
Annual income
$10,761.37
Full MCK calculator →
BEN
BEN
● Live price
5.63%
Share price
$22.91
Annual div
$1.29
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$65.2K
Annual income
$11,735.62
Full BEN calculator →

Portfolio growth — MCK vs BEN

📍 BEN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMCKBEN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MCK + BEN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MCK pays
BEN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCK
Annual income on $10K today (after 15% tax)
$32.41/yr
After 10yr DRIP, annual income (after tax)
$9,147.16/yr
BEN
Annual income on $10K today (after 15% tax)
$478.61/yr
After 10yr DRIP, annual income (after tax)
$9,975.28/yr
At 15% tax rate, BEN beats the other by $828.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCK + BEN for your $10,000?

MCK: 50%BEN: 50%
100% BEN50/50100% MCK
Portfolio after 10yr
$54.7K
Annual income
$11,248.49/yr
Blended yield
20.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCK right now

MCK
Analyst Ratings
1
Strong
24
Buy
6
Hold
Consensus: Buy
Price Target
$982.38
+14.2% upside vs current
Range: $900.00 — $1,085.00
Altman Z
5.9
Piotroski
7/9
BEN
Analyst Ratings
6
Buy
14
Hold
7
Sell
Consensus: Hold
Price Target
$23.50
+2.6% upside vs current
Range: $22.00 — $25.00
Altman Z
1.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCK buys
0
BEN buys
0
No recent congressional trades found for MCK or BEN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMCKBEN
Forward yield0.38%5.63%
Annual dividend / share$3.28$1.29
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR66.7%22.6%
Portfolio after 10y$44.3K$65.2K
Annual income after 10y$10,761.37$11,735.62
Total dividends collected$22.6K$38.7K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyHold
Analyst price target$982.38$23.50

Year-by-year: MCK vs BEN ($10,000, DRIP)

YearMCK PortfolioMCK Income/yrBEN PortfolioBEN Income/yrGap
1← crossover$10,764$63.56$11,390$690.33$626.00BEN
2$11,624$106.59$13,089$900.94$1.5KBEN
3$12,617$179.33$15,191$1,186.21$2.6KBEN
4$13,803$303.26$17,832$1,577.47$4.0KBEN
5$15,286$516.89$21,202$2,121.67$5.9KBEN
6$17,248$891.81$25,576$2,890.42$8.3KBEN
7$20,023$1,567.70$31,362$3,995.15$11.3KBEN
8$24,260$2,835.35$39,170$5,613.10$14.9KBEN
9$31,310$5,352.05$49,945$8,032.75$18.6KBEN
10$44,263$10,761.37$65,177$11,735.62$20.9KBEN

MCK vs BEN: Complete Analysis 2026

MCKHealthcare

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Full MCK Calculator →

BENStock

Franklin Resources, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to individuals, institutions, pension plans, trusts, and partnerships. It launches equity, fixed income, balanced, and multi-asset mutual funds through its subsidiaries. The firm invests in the public equity, fixed income, and alternative markets. Franklin Resources, Inc. was founded in 1947 and is based in San Mateo, California with an additional office in Hyderabad, India.

Full BEN Calculator →
📬

Get this MCK vs BEN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCK vs SCHDMCK vs JEPIMCK vs OMCK vs KOMCK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.